Hba1c (Whole Blood) with Graph

Diabetes

Report in 4Hrs

At Home

No Fasting Required

Details

Measures average blood glucose over the past 2–3 months; essential for diabetes diagnosis and monitoring.

₹149₹525

72% OFF

HbA1c (Whole Blood) with Graph - Comprehensive Medical Test Guide

Why is it done?
- Measures glycated hemoglobin (HbA1c), which reflects average blood glucose levels over the past 2-3 months by showing the percentage of hemoglobin molecules bound to glucose
- Diagnosis of type 2 diabetes mellitus and prediabetes in asymptomatic individuals or those with clinical suspicion of diabetes
- Monitoring glycemic control in patients with established type 1 or type 2 diabetes to assess treatment efficacy
- Risk stratification for diabetes complications in high-risk populations
- Typically performed at baseline for diabetes screening in adults ≥45 years, those with risk factors (obesity, family history, sedentary lifestyle), and at regular intervals (annually or quarterly) for diagnosed diabetic patients
Normal Range
- Normal/Non-diabetic range: Below 5.7% (or <39 mmol/mol)
- Prediabetic range: 5.7% to 6.4% (or 39-46 mmol/mol) - indicates increased risk of developing type 2 diabetes
- Diabetic range: 6.5% or higher (or ≥48 mmol/mol) - diagnostic for diabetes mellitus
- Units of measurement: Percentage (%) or international standard mmol/mol
- Interpretation: Normal results indicate good long-term glucose control; borderline results suggest need for lifestyle modification; elevated results indicate poor glycemic control requiring intervention or treatment adjustment
Interpretation
- HbA1c <5.7%: Normal glucose metabolism with average blood glucose approximately 100 mg/dL; low risk for diabetes development
- HbA1c 5.7-6.4%: Prediabetic state; average blood glucose 101-125 mg/dL; patient at significant risk for progression to type 2 diabetes without intervention
- HbA1c ≥6.5%: Diagnostic for diabetes mellitus; average blood glucose ≥126 mg/dL; indicates chronic hyperglycemia and increased risk for microvascular and macrovascular complications
- HbA1c >8.0% in diabetic patients: Suboptimal glycemic control; indicates need for intensified therapy and lifestyle intervention; associated with increased risk of complications
- HbA1c >10%: Poor glycemic control; high risk for acute complications (diabetic ketoacidosis, hyperglycemic hyperosmolar state) and long-term complications
- Factors affecting readings: Hemoglobinopathies, chronic anemia, hemolytic disease, pregnancy, recent blood transfusion, end-stage renal disease, splenectomy, and certain medications may falsely elevate or lower HbA1c; individual variation in red blood cell lifespan affects results
- Clinical significance: Each 1% increase in HbA1c correlates with approximately 35 mg/dL increase in average blood glucose; used to assess long-term glycemic control independent of acute glucose fluctuations; recommended target <7% for most diabetic patients, though individualized targets are appropriate
Associated Organs
- Primary organ systems involved:
  - Pancreas (insulin production and glucose regulation)
  - Blood glucose metabolism and hematologic system
  - Liver (glucose production and metabolism regulation)
- Medical conditions commonly associated with abnormal results:
  - Type 1 and type 2 diabetes mellitus
  - Prediabetes and impaired glucose tolerance
  - Gestational diabetes mellitus
  - Polycystic ovary syndrome (PCOS)
  - Metabolic syndrome
- Diseases this test helps diagnose or monitor:
  - Diabetes mellitus (primary diagnostic tool)
  - Acromegaly and growth hormone excess
  - Cushing's syndrome
  - Hyperthyroidism
- Potential complications associated with abnormal results:
  - Microvascular complications: diabetic retinopathy, nephropathy, and neuropathy with chronic hyperglycemia
  - Macrovascular complications: increased risk of myocardial infarction, stroke, and peripheral arterial disease
  - Accelerated atherosclerosis and vascular dysfunction
  - Hypoglycemic episodes with overly aggressive treatment
  - Acute metabolic complications: diabetic ketoacidosis and hyperglycemic hyperosmolar state
Follow-up Tests
- For diagnostic confirmation:
  - Fasting plasma glucose (FPG)
  - 2-hour oral glucose tolerance test (OGTT)
  - Repeat HbA1c test for confirmation if initial result is 6.5% or higher
- For assessing glycemic control and related complications:
  - Fasting lipid panel (cholesterol, LDL, HDL, triglycerides)
  - Urine albumin-to-creatinine ratio (UACR) for nephropathy screening
  - Serum creatinine and eGFR for renal function assessment
  - Comprehensive metabolic panel including liver and kidney function tests
- For complication screening:
  - Dilated retinal examination for diabetic retinopathy
  - Monofilament testing for diabetic neuropathy
  - Electrocardiography and stress testing for cardiac risk assessment
  - Carotid ultrasound if cardiovascular disease risk is high
- Monitoring frequency for diagnosed diabetes:
  - Stable patients: HbA1c testing every 6-12 months
  - Patients with suboptimal control or medication changes: every 3 months
  - Prediabetic patients: annual testing or every 6 months if high-risk
- Related tests providing complementary information:
  - Fasting glucose and random blood glucose for point-in-time glucose assessment
  - Continuous glucose monitoring (CGM) for detailed glucose trend analysis
  - C-peptide levels to assess residual beta cell function
  - Thyroid function tests (TSH, free T4) as autoimmune thyroiditis often coexists with type 1 diabetes
Fasting Required?
- Fasting requirement: NO - Fasting is NOT required for HbA1c testing. This is a major advantage of HbA1c as a diagnostic and monitoring tool, as it can be performed at any time of day regardless of food intake
- Specimen requirements:
  - Whole blood sample collected via venipuncture in EDTA (ethylenediaminetetraacetic acid) tube
  - Typical sample volume: 3-5 mL for standard laboratory testing
- Patient preparation:
  - No food or fluid restrictions before test
  - Patient may eat and drink normally prior to collection
  - Can take regular medications unless instructed otherwise
  - Continue normal daily routine including exercise and activities
- Medications to avoid:
  - Generally no medications need to be discontinued for HbA1c testing
  - Inform provider if taking medications known to affect hemoglobin (antiretrovirals, iron supplements, certain chemotherapy agents)
  - Continue diabetes medications as prescribed
- Special considerations:
  - Test can be performed during any season or time of day
  - Recent blood transfusion, bleeding episodes, or conditions affecting red blood cell lifespan should be noted
  - Results should be interpreted in clinical context, not as sole diagnostic criterion

How our test process works!